• PCHRD, Ateneo IPC host 2-day kick-off meeting on eHealth Technologies and Data Governance in ASEAN

    The Philippine Council for Health Research and Development (PCHRD), in partnership with the Institute of Philippine Culture (IPC) of the Ateneo de Manila University, hosted a two-day kick-off meeting on “eHealth Technologies and Data Governance” on 27 to 28 February 2017 at San Alberto Hurtado Hall, Ateneo de Manila University, Quezon City and Capitol Resort Hotel, Lingayen, Pangasinan, respectively.

     Read More
  • Call for collaborative research proposals on health and the environment in the South East Asian and Western Pacific Regions

    The Special Programme for Research and Training in Infectious Diseases (TDR) is calling for collaborative research proposals on health and environment specifically on innovative socioecological strategies for the prevention and control of vector-borne diseases.

    The call is focused on transdisciplinary research on health and environment leading to the development of community-participatory strategies for the prevention and control of vector-borne diseases (VBD). The proposed research project should "utilize an ecosystem-based approach and explore how innovative VBD control tools and strategies can be used more effectively among vulnerable populations."

     Read More
  • ASEAN-NDI, WHO TDR host expert consultation on health and environment

     

    MAKATI CITY, Manila- The ASEAN Network for Drugs, Diagnostics, Vaccines and Traditional Medicines Innovation (ASEAN-NDI) and the World Health Organization Special Programme for Research and Training in Tropical Diseases (WHO TDR) hosted the “Expert Panel Consultation on Health and Environment” on 5-6 April 2016 at the Dusit Thani Manila Hotel.

     Read More
  • Global Forum 2015: ASEAN-NDI initiates collaboration in Health R&D

    The ASEAN Network for Drugs, Diagnostics, Vaccines, and Traditional Medicines Innovation (ASEAN-NDI) conducted two activities during the pre-conference of the Global Forum on Research and Innovation for Health on 24 August 2015 at the Philippine International Convention Center (PICC), Manila. These are the ASEAN-NDI Communities of Practice (CoP) on Drugs, Diagnostics and Vaccines Meeting and the Regional Consultation on R&D Collaboration on Environment and Health.

     Read More
  • Wellcome Trust-MRC Newton Fund Collaboration

    The Newton Fund is a new UK government initiative intended to strengthen research and innovation partnerships between the UK and emerging knowledge economies. In partnership with the Medical Research Council, the Wellcome Trust will deliver Newton Fund research activities within its funding remit in South-east Asia.

     Read More
  • Call for Nominations: 2015 APEC Science Prize for Innovation, Research and Education (ASPIRE) Prize

    Nominations for the 2015 APEC Science Prize for Innovation, Research and Education (ASPIRE) Prize through APEC Policy Partnership on Science, Technology and Innovation (PPSTI) is now open.  The APEC Science Prize for Innovation, Research and Education (“ASPIRE”) is an annual award which recognizes young scientists who have demonstrated a commitment to both excellence in scientific research, as evidenced by scholarly publication and cooperation with scientists from other APEC member economies.

     Read More
  • ASEAN-NDI Initiates Research Collaborations on Traditional Medicine

    With the vision of advancing together as one community, delegates from the ASEAN member states convened on June 26 – 27, 2014 for the 1st ASEAN – Network for Drugs, Diagnostics, Vaccines, and Traditional Medicine Innovation (ASEAN-NDI) Community of Practice on Traditional Medicine Meeting at Dusit Thani Hotel, Makati City, Philippines.

    Presenting the ASEAN-NDI initiatives, Dr. Jaime C. Montoya, the ASEAN-NDI Secretariat Coordinator, emphasized the need to develop collaborative innovations on traditional medicine in addressing the escalating cost and poor access to modern medicine, which were prevalent in some ASEAN countries.

     Read More
  • ASEAN-NDI SBP, catalyst for collaborative innovation in health R & D

    Stakeholders of the ASEAN – Network for Drugs, Diagnostics, Vaccines, and Traditional Medicine Innovation (ASEAN-NDI) convened last June 5 at the Dusit Thani Hotel, Makati City, Philippines, to discuss the network’s Strategic Business Plan (SBP), learn from the best practices/experience of other regional R&D innovation networks in China and Africa, and lay down plans for ASEAN-NDI, including the proposed activities and funding opportunities for the network.

     Read More
  • ASEAN Economic Community (AEC) Biomedical Innovation Forum 2013

    An International Conference and Exhibition on Health Technology for Development (14-16 November 2013, Bangkok, Thailand 2013)

    1. Rationale

    The global biomedical industry continues to grow at impressive rates. The growth is non homogenous.  Asia for example has experienced a growth rate of over 10% per year over the last decade.  While powerhouse countries like China, Korea and Japan have accounted for the majority of the Asian market, domestic growth in South East Asia (ASEAN) countries are fast expanding, and should not be overlooked. In 2015, ten countries in the region will join and become a single market and population, known as the ASEAN Economic Community (AEC).

     Read More
  • Myanmar hosts the ASEAN 63rd Meeting of the COST

    NAY PYI TAW, MYANMAR- Leaders, Delegates, and Representatives from the region are now holding the Association of Southeast Asian Nations (ASEAN) 63rd Meeting of the Committee on Science and Technology (COST) at the Myanmar International Convention Center (MICC) on May 14-18, 2012.

     

     

     

     Read More
  • ASEAN-NDI reviews its Strategic Business Plan

    Task force members of the ASEAN Network for Drug, Diagnostics, and Vaccines Innovation (ASEAN-NDI) held a teleconference at the Asian Institute of Management (AIM) in Makati City last February 28, 2012 to review its draft Strategic Business Plan (SBP).

    “The meeting was called to provide the task force members information on the progress of the SBP project. It also aims to gather reactions and post clarifications on the questionnaire provided prior to the meeting to make sure that the draft report for the project will address issues applicable to most of the countries,” explained Professor Federico Macaranas of AIM, SBP program leader and moderator of the meeting.

     Read More
  • Task Force Members identify strategies for the network

    In continuing its pursuit of establishing a network for the region, ASEAN-NDI conducted a meeting of the Task Force (TF) members held on 20 October 2011 at the Dusit Thani Hotel, Makati City, Philippines. The objective of the meeting is to discuss and agree on the framework/ initial outline of the draft ASEAN-NDI Startegic Business Plan (SBP) and the timelines for consultations/ discussions by the business development expert with the TF members. The meeting was organized to be a venue for the discussion of the SBP for ASEAN-NDI, and identification of strategies geared towards the future implementation of collaborations and partnerships within ASEAN on innovation.

     Read More
  • ASEAN Representatives gear up for ASEAN-NDI launching

    Another milestone in Research & Development (R&D) innovation was accomplished on December 6, 2010 at the Dusit Thani Manila Hotel, Makati City during the meeting of ASEAN representatives and World Health Organization (WHO) officials. The said event was organized to hold the 2nd meeting of Country Coordinators of the ASEAN product R&D mapping for infectious diseases, and consult with other ASEAN representatives regarding the plan for the proposed ASEAN Network for Drugs, Diagnostics and Vaccines Innovation (ASEAN-NDI).

     Read More
NewPictureNewPictureNewPictureNewPictureNewPictureNewPictureNewPictureNewPicture
ASEAN Economic Community (AEC) Biomedical Innovation Forum 2013 Print E-mail

An International Conference and Exhibition on Health Technology for Development (14-16 November 2013, Bangkok, Thailand 2013)

1. Rationale

The global biomedical industry continues to grow at impressive rates. The growth is non homogenous.  Asia for example has experienced a growth rate of over 10% per year over the last decade.  While powerhouse countries like China, Korea and Japan have accounted for the majority of the Asian market, domestic growth in South East Asia (ASEAN) countries are fast expanding, and should not be overlooked. In 2015, ten countries in the region will join and become a single market and population, known as the ASEAN Economic Community (AEC).

This geographical expansion and the new emerging market with an estimated population over 600 million will present great opportunities for all stakeholders in the healthcare and biomedical industry. In terms of technology development, finding sustainable competitive advantage through innovation is definitely a new challenge in the AEC market.

To promote and support the implementation of new health technologies in the AEC market, the National Innovation Agency [NIA] and the French National Alliance for Life Sciences and Health of France [Aviesan] both believe in the concept of sustainable development through an effective integration and management of research, development and innovation process between the academic institutions and the entrepreneurial world in the biomedical field.

Upon our first attempt to achieve this goal, NIA and Aviesan are organizing an International Conference and Exhibition on the biomedical industry by the name of “AEC Biomedical Innovation Forum 2013” which will provide an international platform to exchange knowledge and networking in the biomedical industry in ASEAN. Hopefully, this forum will lead to (a) successful(ly) technology transfer and the implementation of new health technologies and investment in the region, especially in the emerging markets of AEC.

The AEC Biomedical Innovation Forum 2013 will address the critical issues to successfully facilitate the transfer and implementation of innovative health technologies in this region. This conference will provide you with a comprehensive overview of the biomedical industry in the AEC market, with the main focus on challenges and opportunities in Thailand, Laos, Cambodia, Vietnam and the Philippines. Local and international companies will present the latest innovation and technologies that could solve healthcare problems. Finally, funding bodies will discuss funding schemes that would result in the highest benefit for all stakeholders.

The event will be co-organized by the leading agencies of different countries, including NIA from Thailand, Aviesan and OSEO of France as well as the University of California, Los Angeles (UCLA) with support from many private companies and organization such as Cohred and Sanofi (tbc).

2. Objectives

  • To provide the latest innovation, technology development and research in biomedical industry
  • To build a collaborative network between various international organizations from Thailand (NIA) France (Aviesan and OESO) and USA (UCLA) to support implementation of biomedical industry
  • To create a dynamic network between Thailand and neighboring countries in AEC in the field of biomedical industry
  • To promote effective technology transfer and market opportunities as well as investment models in biomedical industry

3. Time and Date

14 – 16 November 2013.

4. Venue

Shangri-La Hotel, Bangkok [Tentative]

5. Event Highlights

  • Implementation of the biomedical industry in Thailand and neighboring countries
  • Global trends in innovations, marketing and investment in the biomedical industry
  • Innovative technologies in telemedicine, diagnostic equipment and clinical devices
  • Technology transfer and implementation models to support the biomedical industry, including funding schemes, intellectual property and social issues
  • Exhibition of biotech companies from France US, and Asian countries

6. Target participants (Who should attend?)

1)      For a conference, a total of 300 delegates including;

  • Public health officers from Laos, Cambodia and Vietnam (by invitation)
  • Scholars, researchers, physicians, practitioners involved in research and development in the biomedical field from Thailand and abroad
  • Manufacturers and distributors in the biomedical industry in Thailand and abroad
  • Regulatory affairs and legislative agencies

2)      For an exhibition, a total of 3,000 visitors are expected, including;

  • Scholars, researchers, physicians, practitioners involved in research and development in the biomedical field from Thailand and abroad
  • Manufacturers and distributors in the biomedical industry in Thailand and abroad
    • The general public

7. Exhibitor Profile

Main exhibitors are from four countries: France, USA, Thailand and Canada

  • Manufacturers in diagnostic/therapeutic devices, equipment in telemedicine technology and clinical instruments
  • Biotech companies
  • Funding agencies and organizations
  • Research institutes, and universities

8. Exhibitor Information [Tentative]

Exhibition size: Gross area 600 m2

Standard booth size: 3 m x 3 m

Anticipated number of exhibitors: 30 companies



Organized by:

Thailand’s National Innovation Agency (NIA)

with the participation of

French National Alliance for Life Sciences and Health of France (Aviesan)

University of California, Los Angeles (UCLA)

Asper Clinical Research Institute-St. Boniface Hospital (ACRI-Canada)

Financement de l'innovation et de la croissance des PME (OSEO) (tbc)

 

Supported by

Cohred

Sanofi

Medicen

International Academy of Cardiovascular Sciences (IACS)

 

Please visit http://www.nia.or.th/biomed2013/ for more details.

 


 

Content Management

Not a contributor?
Apply for a contributor account


Capabilities' Survey

ASEAN - NDI is conducting a survey of institutions involved in research and development (R & D), manufacturing, and production of drugs, diagnostics, vaccines, and traditional medicine. Data gathered from this survey will serve as inputs in mapping the capabilities of ASEAN-member countries and in assessing the needs of our region in R & D.

Who should fill out this questionnaire:
The recommended individual is any of, but not limited to, the following: (1) president/dean/ head of the institution; (2) senior research director; (3) head of program or unit conducting research; or (4) a researcher.


NEWSLETTERS

January - March 2015 Issue


October - December 2014 Issue

July - September 2014 Issue

April - June 2014 Issue